SpiroChem will participate in the 21st Annual Peptide Therapeutics Symposium, taking place at the Scripps Seaside Forum in La Jolla, California, from October 20–21, 2026.
Established as an annual scientific meeting, the symposium brings together experts from academia and the biopharmaceutical industry to exchange on advances in peptide research, drug discovery and therapeutic candidate development.
The two-day program will focus on developments in peptide science and technologies supporting the discovery and progression of peptide-based therapeutics, providing a dedicated setting for scientific discussion across the field.
Attending for SpiroChem:
Gerhard Mueller, PhD – CSO
Laurence Jung, PhD – Innovative Solution Developer
The symposium provides an opportunity to connect with the peptide therapeutics community and exchange on medicinal chemistry approaches, peptide optimization and the development of more drug-like peptide-based candidates.
We look forward to engaging with experts in peptide research and drug discovery in La Jolla and exploring new opportunities for scientific collaboration.
